Fulvestrant With or Without Lapatinib and/or Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer That Progressed After Previous Aromatase Inhibitor Therapy
PHASE3
RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone th...
This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c Versus Placebo in Combination With Letrozole or Anastrozole ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer.
PHASE3
This is a multicenter, randomized, double-blind, placebo-controlled Phase I...
Status
Unknown
Location
Cancer Hospital, Chinese Academy of Medical Sciences